Pharmacotherapy change patterns after fragility fracture in patients receiving bone-active medication: a fracture liaison service quality improvement cohort study

Purpose We examined pharmacotherapy change patterns in fragility fracture patients who fractured while taking bone active medication, and were screened by Ontario’s Fracture Screening and Prevention Program (FSPP). A secondary objective was to identify baseline characteristics associated with receiv...

Full description

Saved in:
Bibliographic Details
Published in:BMC musculoskeletal disorders 2026-02, Vol.27 (1), p.192
Main Authors: Ansari, Hina, Yang, Alan, Sujic, Rebeka, Bogoch, Earl R., Elliot-Gibson, Victoria, Jain, Ravi, Weldon, Jennifer, Linton, Denise, Sale, Joanna E.M.
Format: Article
Language:English
Subjects:
Age
Bisphosphonates
Bone density
Clinical medicine
Clinical practice guidelines
Cohort analysis
Comorbidity
Drug therapy
Epidemiology
Fracture liaison service
Fractures
Fragility fracture
Internal Medicine
Medicine
Medicine & Public Health
Orthopedics
Osteoporosis
Parathyroid hormone
Patients
Pharmacotherapy
Prevention
Quality control
Quality improvement
Rehabilitation
Rheumatology
Risedronic acid
Specialist
Sports Medicine
Citations: Items that this one cites
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!